ORTHOPEDIATRICS CORP (KIDS)
$23.65+$0.33 (+1.42%) Today
Latest KIDS Insider Trades
Jennifer N. Pritzker - 10% Owner
Jennifer N. Pritzker - 10% OwnerJennifer N. Pritzker - 10% OwnerJennifer N. Pritzker - 10% OwnerOrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.
https://www.orthopediatrics.comSEC filings for KIDS on EDGAR
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 9 | 114,900 | $2.83M |
| Grant or award | 10 | 222,064 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
21 Form 4 filings on record, the earliest from Dec 30, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jennifer N. Pritzker - 10% Owner | Open-market sale | Common Stock | 4,000 | $25.75 | $103K | |
| Jennifer N. Pritzker - 10% Owner | Open-market sale | Common Stock | 16,300 | $24.74 | $403K | |
| Jennifer N. Pritzker - 10% Owner | Open-market sale | Common Stock | 18,000 | $24.28 | $437K | |
| Squadron Capital LLC - 10% Owner | Open-market sale | Common Stock | 4,000 | $25.75 | $103K | |
| Squadron Capital LLC - 10% Owner | Open-market sale | Common Stock | 16,300 | $24.74 | $403K | |
| Squadron Capital LLC - 10% Owner | Open-market sale | Common Stock | 18,000 | $24.28 | $437K | |
| David R. Pelizzon - Director | Open-market sale | Common Stock | 4,000 | $25.75 | $103K | |
| David R. Pelizzon - Director | Open-market sale | Common Stock | 16,300 | $24.74 | $403K | |
| David R. Pelizzon - Director | Open-market sale | Common Stock | 18,000 | $24.28 | $437K | |
| David R. Pelizzon - Director | Grant or award | Common Stock | 11,436 | $0.00 | - | |
| Bryan W. Hughes - Director | Grant or award | Common Stock | 11,436 | $0.00 | - | |
| Kelly Laine Fischer - Director | Grant or award | Common Stock | 11,436 | $0.00 | - | |
| Samuel D. Riccitelli - Director | Grant or award | Common Stock | 11,436 | $0.00 | - | |
| Harold Ruf - Director | Grant or award | Common Stock | 11,436 | $0.00 | - | |
| David R. Bailey - Officer | Grant or award | Common Stock | 119,140 | $0.00 | - | |
| Jimmy Duane McDonald - Director | Grant or award | Common Stock | 11,436 | $0.00 | - | |
| (Reynolds) Marie C. Infante - Director | Grant or award | Common Stock | 11,436 | $0.00 | - | |
 Mark C. Throdahl - Director | Grant or award | Common Stock | 11,436 | $0.00 | - | |
 George Sinclair Mitchell Dyer - Director | Grant or award | Common Stock | 11,436 | $0.00 | - | |
 Daniel J. Gerritzen - Officer | Gift | Common Stock | 2,479 | $0.00 | - | |
 Joseph W. Hauser - Officer | Grant or award | Common Stock | 65,700 | $0.00 | - | |
| Joseph W. Hauser - Officer | Open-market sale | Common Stock | 8,596 | $17.25 | $148K | |
 Fred Hite - Officer | Grant or award | Common Stock | 77,405 | $0.00 | - | |
| Fred Hite - Officer | Open-market sale | Common Stock | 12,993 | $17.25 | $224K | |
| David R. Bailey - Officer | Open-market sale | Common Stock | 19,535 | $17.25 | $337K | |
 Gregory A. Odle - Officer | Grant or award | Common Stock | 47,380 | $0.00 | - | |
| Gregory A. Odle - Officer | Open-market sale | Common Stock | 8,433 | $17.25 | $145K | |
| Daniel J. Gerritzen - Officer | Grant or award | Common Stock | 47,380 | $0.00 | - | |
| Daniel J. Gerritzen - Officer | Open-market sale | Common Stock | 8,614 | $17.25 | $149K | |
| Fred Hite - Officer | Open-market purchase | Common Stock | 5,076 | $19.41 | $99K | |
| David R. Bailey - Officer | Gift | Common Stock | 1,500 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Squadron Capital, LLC | 10% Stockholder | 700,000 | $18.36M | View on EDGAR |
ORTHOPEDIATRICS CORP (KIDS) had 13 insider filings in the last 90 days, with the most recent on 2026-08-26. The full record for KIDS runs to 21 Form 4 filings, the earliest from 2024-12-30. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of KIDS were filed in the last 90 days. 1 purchase is on record for this company.
9 insider sales of KIDS were filed in the last 90 days, totaling $2.83M.
This page tracks KIDS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add KIDS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
$KLCKinderCare Learning Companies, Inc.
$KLRSKalaris Therapeutics, Inc.
$KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.
$KNSAKiniksa Pharmaceuticals International, plc
$KODKodiak Sciences Inc.
$KPRXKIORA PHARMACEUTICALS INC
$KPTIKaryopharm Therapeutics Inc.
$KRMDKORU Medical Systems, Inc.
$KRONKronos Bio, Inc.
$KROSKeros Therapeutics, Inc.Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
